News

« Previous 12345 Next »
Viewing Page 1 of 5 | Showing Results 1 - 10 of 47

National Cancer Institute scientist joins Providence, honored nationally for unique and promising Immunotherapy research

May 04, 2017

It has been a busy and exciting start to 2017 for immunotherapy researcher Eric Tran, Ph.D., and it could make a great difference in the lives of people fighting cancer.

Targeted therapy and immunotherapy studies for people with lung cancer

February 22, 2017

More than 20 studies of promising new therapies for lung cancer patients are open now at Providence Cancer Center, including studies of targeted therapies and novel immunotherapy combinations.

Combination Immunotherapy with Galectin-3 Inhibitor GR-MD-02 Enhances Effects in Pre-clinical Models and Early Results of Phase 1 Clinical Trials

February 07, 2017

First-in-human data presented at GTCBio 9th Immunotherapeutics & Immunomonitoring Conference NORCROSS, Ga....

Immunotherapy for Breast Cancer

January 27, 2017

Immunotherapy is a treatment approach that harnesses the immune system to recognize, attack and eliminate cancer. The opportunity to conduct...

Phase I Research at Providence Cancer Center

December 23, 2016

Patients with a variety of cancer types are eligible to receive new and promising treatments when they participate in Phase I research studies at Providence Cancer Center.

Melanoma Research

December 02, 2016

Providence physicians and scientists have been leading the way in melanoma research and treatment for more than 20 years. Our findings have resulted in new ways to boost immune response, which has improved the standard of care for patients with this aggressive malignancy. 

Oral, head and neck cancer research at Providence Cancer Center

October 21, 2016

Providence Oral, Head and Neck Cancer Clinic offers world-class care for patients with benign and malignant tumors of the oral cavity (mouth), tongue, pharynx (throat), larynx (voice box), nose, paranasal sinuses, salivary glands and thyroid gland, as well as tumors at the skull base. Our medical and surgical oncology teams work collaboratively to start patients on treatment regimens very quickly. 

Gastrointestinal cancer research at Providence Cancer Center

September 30, 2016

Providence Cancer Center is actively involved in gastrointestinal cancer research, focusing our attention on cancers of the upper (esophagus and stomach), middle (pancreas, liver, gall bladder, bile ducts and small intestine) and lower (colon, rectum and anus) gastrointestinal tract.

NIH awards two grants to Drs. Crittenden and Gough

September 12, 2016

The National Institutes of Health has awarded two significant grants to Providence Cancer Center researchers

New hope for cancer patients; Providence joins international research network formed by Bristol-Myers Squibb

August 24, 2016

An unprecedented international collaboration promises to take cancer treatment research to a new level and allow substantially more patients at Providence Cancer Center to take part in clinical trials every year.

« Previous 12345 Next »
Viewing Page 1 of 5 | Showing Results 1 - 10 of 47